Eumed Biotechnology Co. Ltd. was established in January 2001. Developing of high Quality Management biosensors and diagnostic reagent are our primary goals.Our team have gained many academic achievements in biotechnology and molecular biology for clinical applications even before founding of Eumed. It is our conviction to become one of the best Blood BGM System System and diagnostic reagents manufacturer in the world.

Resulting from our research and development efforts, Eumed has introduced four products lines :Blood Glucose Monitoring System, cHPV Detection System, Safety Lancets system and SO2 Detecting System for Foods, Compared to the available self-monitoring blood glucose systems, our BGM delivers superior performance in accuracy, stability, speed and less sample volume. The cHPV Detection System was developed to detect human papilloma virus during screening for cervical cancer. Clinical trials have been completed with excellent results: our system achieved up to 98% sensitivity and accuracy. The one-time use Eusafe Safety lancets system quarantees to avoid cross-contanmination and accidental puncturing.

In addition to these two ready-to-use products, several new and innovative biosensors will be introduced onto the market in the near future.